SCHEMBL18200733

SCHEMBL18200733

c1ccc(-c2nc(-c3ccc(-c4cccc(-c5nc6ccccc6c6c5ccc5ccccc56)c4)cc3)nc(-c3ccccn3)n2)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 2/20 0.41
TSHR P16473 4/20 0.40
HSD17B10 Q99714 3/20 0.40
MAPK1 P28482 2/20 0.40
KDM4E B2RXH2 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
ATM Q13315 1/20 0.39
MAPT P10636 4/20 0.39
ALDH1A1 P00352 3/20 0.39
POLB P06746 1/20 0.39
LMNA P02545 4/20 0.38
RAB9A P51151 3/20 0.38
TP53 P04637 2/20 0.38
PKM P14618 2/20 0.38
KLF5 Q13887 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18346948 0.97 METAP1 (0.42) METAP1TSHRHSD17B10MAPK1KDM4E
SCHEMBL18200806 0.96 METAP1 (0.41) METAP1TSHRHSD17B10MAPK1KDM4E
SCHEMBL18200884 0.96 METAP1 (0.43) METAP1TSHRHSD17B10MAPK1KDM4E
SCHEMBL18200731 0.94 METAP1 (0.44) METAP1TSHRHSD17B10MAPK1KDM4E
SCHEMBL18200993 0.92 METAP1 (0.46) METAP1TSHRHSD17B10MAPK1KDM4E
SCHEMBL18200497 0.92 TSHR (0.41) METAP1TSHRHSD17B10MAPK1KDM4E
SCHEMBL18200490 0.92 TSHR (0.41) METAP1TSHRHSD17B10MAPK1KDM4E
SCHEMBL18200413 0.92 TSHR (0.39) METAP1TSHRHSD17B10MAPK1KDM4E
SCHEMBL18200341 0.91 METAP1 (0.47) METAP1TSHRHSD17B10MAPK1KDM4E
SCHEMBL18201255 0.90 TSHR (0.39) METAP1TSHRHSD17B10MAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 METAP1 2608/4885TSHR 4253/4885HSD17B10 1689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.